Showing results (101-110 of 155) with videos related to
Sort By:
Pageof 16
The Lancet. Respiratory Medicine|February 6, 2022
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trialE Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2024
Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic ArthritisMelissa Tordoff, Samantha L Smith, Saskia Lawson-Tovey, et al.Journal of Clinical Medicine|August 10, 2024
Diagnosis of Chronic Granulomatous Disease: Strengths and Challenges in the Genomic EraConor J O'Donovan, Lay Teng Tan, Mohd A Z Abidin, et al.Arthritis Care & Research|November 14, 2024
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 TrialHermine I Brunner, Anna Shmagel, Gerd Horneff, et al.The New England Journal of Medicine|April 27, 2017
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic ArthritisAthimalaipet V Ramanan, Andrew D Dick, Ashley P Jones, et al.Arthritis & Rheumatology (Hoboken, N.J.)|October 20, 2020
Platelet Glycoprotein Ib α-Chain as a Putative Therapeutic Target for Juvenile Idiopathic Arthritis: A Mendelian Randomization StudyShan Luo, Sarah L N Clarke, Athimalaipet V Ramanan, et al.Clinical and Experimental Rheumatology|March 31, 2018
The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart reviewSusan Shenoi, Gerd Horneff, Michal Cidon, et al.Ophthalmology|October 19, 2018
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic ArthritisDyfrig A Hughes, Giovanna Culeddu, Catrin O Plumpton, et al.Arthritis and Rheumatism|March 1, 2007
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisJack Bleesing, Anne Prada, David M Siegel, et al.The Lancet. Child & Adolescent Health|September 21, 2020
A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi processRachel Harwood, Benjamin Allin, Christine E Jones, et al.Pageof 16